Skip to content
GLP-1 Scorecard
Menu
Site position #84

Science & Co

Published by GLP-1 ScorecardUpdated

States in its own footer that it is not a compounding facility, and explains its own asterisk in its own FAQ — two things almost nothing else here does.

Visit Science & CoWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$149/mo month-to-month ($79 only on a 12-month plan)
Tirzepatide
$199/mo month-to-month ($125 only on a 12-month plan)
Coverage
Not publicly listed
Brand-name
Not confirmed

Weigh Science & Co against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value74/100
Dose & formulation74/100
Clinical oversight76/100
Labs & monitoring55/100
Fulfillment80/100
Contract terms82/100

Strengths

  • States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
  • Its own FAQ names the commitment behind the headline: "Plans start at $125 a month on the 12 month plan"
  • The printed saving corroborates the reference price — 125 divided by 199 is 63%, exactly the "Save 37%" shown
  • "Same Price, Any Dose", with no hidden fees, no monthly membership and free shipping stated in the FAQ
  • Names its operating entity and state of incorporation, and says every batch is third-party tested

What to consider

  • The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
  • Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
  • It says it is not a compounding facility but never names the pharmacy that is
  • No lab or monitoring protocol is published
  • Injection only on the pages read — no oral route and no brand lane

Bottom line — Grade C

Best for: A twelve-month committer, or anyone who values a company saying plainly what it is and is not.

Site position #84 of 542. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Science & Co — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Science & Co's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Science & Co's site. Not medical advice; see our disclosure.

← Back to the scorecard